SCHEMBL2884082

SCHEMBL2884082

Cc1cc(Cn2nc(C(F)(F)CC(F)(F)F)cc2C(F)(F)CC(F)(F)F)ccc1N

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SKP2 Q13309 1/20 0.35
ADORA3 P0DMS8 1/20 0.34
ADORA2A P29274 1/20 0.34
ADORA2B P29275 1/20 0.34
ADORA1 P30542 1/20 0.34
GRIA2 P42262 1/20 0.34
POLB P06746 1/20 0.32
SLC2A1 P11166 1/20 0.32
ALDH1A1 P00352 1/20 0.31
PTGDR2 Q9Y5Y4 1/20 0.31
MEN1 O00255 1/20 0.30
NPC1 O15118 1/20 0.30
RAB9A P51151 1/20 0.30
KMT2A Q03164 1/20 0.30
HDAC3 O15379 1/20 0.30
HDAC4 P56524 1/20 0.30
HDAC1 Q13547 1/20 0.30
HDAC7 Q8WUI4 1/20 0.30
HDAC2 Q92769 1/20 0.30
HDAC10 Q969S8 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1831039 0.82 GRIA2 (0.47) SKP2ADORA3ADORA2AADORA2BADORA1
SCHEMBL2889650 0.80 SKP2 (0.36) SKP2ADORA3ADORA2AADORA2BADORA1
SCHEMBL2161565 0.79 GRIA2 (0.41) SKP2ADORA3ADORA2AADORA2BADORA1
SCHEMBL2884078 0.77 GRIA2 (0.35) SKP2ADORA3ADORA2AADORA2BADORA1
SCHEMBL12402161 0.76 HPGD (0.46) SKP2POLBALDH1A1MEN1KMT2A
SCHEMBL2889521 0.72 KLKB1 (0.34) SKP2ADORA3ADORA2AADORA2BADORA1
SCHEMBL12402591 0.72 HDAC3 (0.37) SKP2ADORA3ADORA2AADORA2BADORA1
SCHEMBL1834616 0.71 HDAC3 (0.36) SKP2ADORA3ADORA2AADORA2BADORA1
SCHEMBL13335218 0.70 ADORA3 (0.39) SKP2ADORA3ADORA2AADORA2BADORA1
SCHEMBL1843882 0.70 SKP2 (0.42) SKP2ADORA2AGRIA2POLBSLC2A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100130743-A1 HETEROCYCLE-SUBSTITUTED, N-PHENYL-PHTHALAMIDE DERIVATIVES, RELATED COMPOUNDS AND THEIR USE AS INSECTICIDES BAYER CROPSCIENCE AG (DE) 2010-05-27 US disclosed
US-7674807-B2 Heterocycle-substituted n-phenyl-phthalamide derivatives, related compounds and their use as insecticides BAYER CROPSCIENCE AG (DE) 2010-03-09 US disclosed
US-20070299085-A1 N1-((Pyrazol-1-Ymethyl)-2-Methylphenyl)-Phatalamide Derivatives And Related Compounds Insecticides BAYER CROPSCIENCE AG (DE) 2007-12-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100130743-A1 HETEROCYCLE-SUBSTITUTED, N-PHENYL-PHTHALAMIDE DERIVATIVES, RELATED COMPOUNDS AND THEIR USE AS INSECTICIDES DDT, SQOR, CYP2S1 SKP2 1205/4885ADORA3 3609/4885ADORA2A 4049/4885
US-20070299085-A1 N1-((Pyrazol-1-Ymethyl)-2-Methylphenyl)-Phatalamide Derivatives And Related Compounds Insecticides CHRM1, KCNH1, DDT SKP2 1596/4885ADORA3 1259/4885ADORA2A 2374/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.